Point of view on the vaccination against COVID-19 in patients with autoimmune inflammatory rheumatic diseases

Victoria Furer*, Christien Rondaan, Nancy Agmon-Levin, Sander Van Assen, Marc Bijl, Meliha Crnkic Kapetanovic, Annette De Thurah, Ulf Mueller-Ladner, Daphna Paran, Karen Schreiber, Klaus Warnatz, Nico M. Wulffraat, Ori Elkayam

*Kontaktforfatter for dette arbejde

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

4 Downloads (Pure)

Abstrakt

In view of the COVID-19 pandemic, there is an unmet clinical need for the guidelines on vaccination of patients with autoimmune inflammatory rheumatic diseases (AIIRD). This position paper summarises the current data on COVID-19 infection in patients with AIIRD and development of vaccines against COVID-19, discusses the aspects of efficacy and safety of vaccination, and proposes preliminary considerations on vaccination against COVID-19 in patients with AIIRD, mainly based on the expert opinion and knowledge on the use of other vaccines in this population of patients.

OriginalsprogEngelsk
Artikelnummere001594
TidsskriftRMD Open
Vol/bind7
Udgave nummer1
ISSN2056-5933
DOI
StatusUdgivet - 24. feb. 2021

Bibliografisk note

Publisher Copyright:
©

Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.

Fingeraftryk Dyk ned i forskningsemnerne om 'Point of view on the vaccination against COVID-19 in patients with autoimmune inflammatory rheumatic diseases'. Sammen danner de et unikt fingeraftryk.

Citationsformater